Skip to content
Screener

CapEx at other companies

Amgen logo
AmgenAMGN
$513M+39.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$240.2M+9.7%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$675K+22,400%
Regenxbio logo
RegenxbioRGNX
$760K+94.4%
Immunome logo
ImmunomeIMNM
$3M-18.1%
CG Oncology logo
CG OncologyCGON
$468K+3,243%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$1.01B+160%
Enterprise value$967.91M+162%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The source filing: Replimune Group’s 10-Q, filed February 3, 2026.

Filed
Feb 3, 2026, 8:12 AM EST
Fiscal quarter
Q3 FY2026
Calendar quarter
Q4 2025
Accession
0001628280-26-004805
Line itemNine Months Ended December 31, 2025Nine Months Ended December 31, 2024
Other non-current liabilities(584)480
Net cash used in operating activities(224,183)(138,519)
Cash flows from investing activities:
Purchases of property, plant and equipment and software capitalization(4,218)(5,553)
Purchase of short-term investments(73,941)(331,953)
Proceeds from sales and maturities of short-term investments302,496321,410
Net cash provided by (used in) investing activities224,337(16,096)
Cash flows from financing activities:

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Replimune Group's capex?
Replimune Group (REPL) reported capex of $135K in Q4 2025.
How has Replimune Group's capex changed year-over-year?
Replimune Group's capex decreased by 92.5% year-over-year, from $1.8M to $135K.
What is the long-term trend for Replimune Group's capex?
Over 3 years (2022 to 2025), Replimune Group's capex has grown at a 42.0% compound annual growth rate (CAGR), from $2.34M to $6.69M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Replimune Group's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude